Thiabendazole (với nhiều biệt dược khác nhau như Mintazol, Niczen) là một trong nhũng thuốc có hiệu lực cao trong điều trị một số bệnh giun tròn ở người và điều trị cả hội chứng ấu trùng di chuyển ở da niêm mạc hay ở phủ tạng có hiệu quả với tác dụng ngoại ý thấp.
Nhằm chia sẻ với các đồng nghiệp về các ấn bản nghiên cứu về hiệu lực thuốc này, chúng tôi xin giới thiệu một số ấn bản liên quan đến đánh giá các thuốc này trên thế giới.
1.A randomized comparative study of albendazole and thiabendazole in chronic strongyloidiasis. [1995.12]
5.Thiabendazole vs. albendazole in treatment of toxocariasis: a clinical trial. [1989.10]
6.Topical treatment of tungiasis: a randomized, controlled trial. [2003.10]
8.Cutaneous larva migrans: clinical features and management of 44 cases presenting in the returning traveller. [2001.09]
9.Blinded, placebo‐controlled trial of antiparasitic drugs for trichinosis myositis. [2000.07]
10.Failure of mebendazole in treatment of human hookworm infections in the southern region of Mali. [1997.07]
11.Chemotherapy of African AIDS diarrhoea: a preliminary study. [1993.01]
13.Randomized clinical trial on ivermectin versus thiabendazole for the treatment of strongyloidiasis. [2011.07]
16.Factors affecting the synergy of thiabendazole, sodium bicarbonate, and heat to control postharvest green mold of citrus fruit. [2008.11.26]
17.Efficacy of thiabendazole, mebendazole, levamisole and ivermectin against gullet worm, Gongylonema pulchrum: in vitro and in vivo studies. [2008.01.25]
18.[Miticidal efficacy of thiabendazole against Otodectes cynotis (Hering, 1838) in dogs] [2006.10]
19.[Thiabendazole for the control of Strongyloides stercoralis infection in a hyperendemic area in Peru] [2005.10]
20.A novel genotoxic aspect of thiabendazole as a photomutagen in bacteria and cultured human cells. [2005.09.15]
21.Effect of thiabendazole on some rat hepatic xenobiotic metabolising enzymes. [2004.06]
22.Synthesis, X‐ray crystal structure, antimicrobial activity and photodynamic effects of some thiabendazole complexes. [2004.02]
23.Effects of thiabendazole in Mansonella perstans filariasis. [2003.12]
24.Treatment of pediculosis capitis with thiabendazole: a pilot study. [2003.12]
25.Residue uptake and storage responses of Tarocco blood oranges after preharvest thiabendazole spray and postharvest heat treatment. [2002.04.10]
27.Chronic toxicity of thiabendazole (TBZ) in CD‐1 mice. [2001.12.28]
28.Treatment of widespread cutaneous larva migrans with thiabendazole. [2001.11]
29.Nematocidal activities of thiabendazole and ivermectin against the larvae of Strongyloides ratti and S. venezuelensis. [2001.08.31]
30.Thiabendazole induces urinary tract toxicity in male ICR mice. [2001.04.12]
31.Developmental toxicity of orally administered thiabendazole in ICR mice. [2001.04]
33.Thiabendazole for the treatment of strongyloidiasis in patients with hematologic malignancies. [2000.09]
34.[Cholestatic hepatitis ascribed to the use of thiabendazole] [1998.06.06]
35.[Hepatic transplantation for severe ductopenia related to ingestion of thiabendazole] [1997]
37.Subchronic toxicity of thiabendazole (TBZ) in ICR mice. [1996.08]
38.Albendazole versus thiabendazole as therapy for trichinosis: a retrospective study. [1996.06]
39.Murine strongyloidiasis: the effects of cyclosporin A and thiabendazole administered singly and in combination. [1995.04]
40.Fasciola hepatica: mebendazole and thiabendazole pharmacokinetics in sheep. [1994.09]
44.Developmental toxicity of orally administered thiabendazole in Sprague‐Dawley rats and New Zealand white rabbits. [1993.03]
46.Treatment of Strongyloides stercoralis hyperinfection syndrome with thiabendazole administered per rectum. [1993.01]
49.Prodrugs of thiabendazole with increased water‐solubility. [1992]
50.Chronic oral toxicity and carcinogenicity study of thiabendazole in rats. [1991.11]
51.Identification of thiabendazole‐resistant cyathostome species in Louisiana. [1991.08]
53.Resistance of population‐B equine strongyles to thiabendazole, oxfendazole, and phenothiazine (1981 to 1987). [1991.08]
54.[New trial with thiabendazole for treatment of human strongyloidiasis] [1991.03]
55.[Treatment of strongyloidiasis with mebendazole and its combination with thiabendazole] [1990.11]
57.Effect of selection pressure for thiabendazole resistance on fitness of Haemonchus contortus in sheep. [1990.04]
58.Effect of thiabendazole and fenbendazole on glucose uptake and carbohydrate metabolism in Trichuris globulosa. [1990.03]
59.Micronodular cirrhosis after thiabendazole. [1989.06]
62.[Larva migrans “saxoniae”: larva migrans infection in Saxony] [2004.01]
63.Field evaluation of the efficacy of fenbendazole in captive wild ruminants. [2005.11.05]
64.Cutaneous larva migrans: case report with current recommendations for treatment. [2005.05]
65.[Purpura in patient with disseminated strongiloidiasis] [2005.05]
66.An unusual case of ectopic tungiasis with pseudoepitheliomatous hyperplasia. [2004.12]
68.[Severe anguilluliasis in a chronic haemodialysis patient] [2005.01.29]
69.[Nosology and epidemiology of human toxocarosis‐the recent situation in Austria] [2004]
70.An in vitro larval motility assay to determine anthelmintic sensitivity for human hookworm and Strongyloides species. [2004.11]
71.Pulmonary strongyloidiasis in a patient receiving prednisolone therapy. [2004.08]
72.Benzimidazole resistance in cyathostomin populations on horse farms in western Anatolia, Turkey. [2004.08]
74.Toxocariasis of the central nervous system: with report of two cases. [2004.03]
75.Strongyloidiasis in patients at a comprehensive cancer center in the United States. [2004.04.01]
76.A survey of anthelmintic resistant nematode parasites in Scottish sheep flocks. [2003.11.03]
77.Cutaneous larva migrans. [2003.10]
79.Strongyloides hyperinfection in a patient with sarcoidosis. [2003.03]
80.Severe drug rashes in three siblings simultaneously. [2003.05]
81.[Selective vs. mass treatment with antihelminthic drugs: experience in two hyperendemic communities] [2003.01]
82.[Toxocariasis: clinical and laboratory features in 54 patients] [2003.05]
83.Treatment of cutaneous larva migrans and Toxocara infection. [2003.04]
84.[A case of parasitism by Rhabditis sp in a child from Goiania, Goias, Brazil] [2002.09]
85.Massive infestation of cutanea larva migrans. [2002.10]
86.[A case of toxocariasis with eosinophil‐rich pleural effusion] [2002.06]
87.[DNA damage in female workers exposed to pesticides in banana plantations at Limon, Costa Rica] [2002.06]
89.Opinion on the diagnosis and treatment of human trichinellosis. [2002.08]
90.Induction of aneuploidy in male mouse germ cells detected by the sperm‐FISH assay: a review of the present data base. [2002.07.25]
91.Treatment failure in intestinal strongyloidiasis: an indicator of HTLV‐I infection. [2002.03]
92.Human strongyloidiasis in AIDS era: its zoonotic importance. [2002.03]
94.Cutaneous larva migrans contracted in England: a reminder. [2001.07]
95.[Disseminated strongyloidiasis] [2001.04.28]
96.Reappearance of a remotely acquired infection. [1997.09]
97.Treatment of larva migrans cutanea (creeping eruption): a comparison between albendazole and traditional therapy. [2001.01]
98.Screening for Strongyloides infection among the institutionalized mentally disabled. [2001.01]
99.High circulating proviral load with oligoclonal expansion of HTLV‐1 bearing T cells in HTLV‐1 carriers with strongyloidiasis. [2000.10.12]
100.[A rare cause of asthma exacerbation: systemic anguilluliasis] [2000.02]
